Genor Biopharma Holdings Limited (6998.HK) - Stock Prices, Stock Peers & Analysis

Home
6998.HK

Company Name	Genor Biopharma Holdings Limited
Symbol	6998.HK
Currency	HKD
Price	1.65
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	852,233,771
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	0.85 - 3.25
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. Feng Guo Ph.D.
Website	https://www.genorbio.com

An error occurred while fetching data.

About Genor Biopharma Holdings Limited

Genor Biopharma Holdings Limited, a biopharmaceutical company, focuses on developing and commercializing oncology and autoimmune drugs in China and internationally. The company's principal drug candidates include GB242, an infliximab (Remicade) biosimilar for the treatment of rheumatoid arthritis, ankylosing spondylitis, psoriasis, adult ulcerative colitis, adult and pediatric crohn's disease, and fistulising